In addition to osteoblasts, AAV9 targets OCs to drive RNAi-mediated silencing of the key OC regulators RANK and CTSK, which we show have clinical relevance as genetic targets to prevent osteoporosis. The gene discussed is TNFRSF11A; the disease is osteoporosis.